Literature DB >> 27342962

DNA Damage Is a Potential Marker for TP53 Mutation in Colorectal Carcinogenesis.

José Ricardo Scalise1, Regina Caeli Guerra Poças1, Thamy Pelatieri Caneloi2, Camila Oliveira Lopes2, Danilo Toshio Kanno2, Mayara Gonçalves Marques2, Júlio Cesar Martins Valdivia2, Felipe Rodrigues Maximo2, José Aires Pereira3, Marcelo Lima Ribeiro1, Denise Gonçalves Priolli4,5.   

Abstract

PURPOSE: The ability to measure oxidative DNA damage in a tissue allows establishment of the relationship between DNA damage and mutations in normal and neoplastic cells. It is well known that TP53 is a key inhibitor of tumor development and preserves the genome integrity in each cell. The aim of the present study was to investigate the relationship between DNA damage and TP53 mutation in colorectal adenoma and adenocarcinoma, and the value of DNA damage as potential marker of TP53 mutation in non-tumor tissues adjacent to colon malignant lesions.
METHODS: Tissue samples were obtained by colonoscopy from patients with adenoma and/or adenocarcinoma and from healthy volunteers. Diagnosis was defined by histopathology. Immunohistochemistry with computer-assisted image analysis was performed to quantify TP53 mutation. Oxidative DNA damage was determined by comet assay. Statistical analyses were performed with 5 % of significance level.
RESULTS: The TP53 level was higher in non-tumor tissues from tumor patients than in normal tissues from healthy volunteers (p = 0.01). Likewise, higher TP53 levels were observed in tumor tissues compared with the non-tumor tissues (p = 0.00). Oxidative DNA damage levels were higher in tumor tissues than in non-tumor tissues (p = 0.00). The amount of TP53 (p = 0.00) and oxidative DNA damage (p = 0.00) in normal and tumor tissue was related. The relationship between oxidative DNA damage and TP53 mutation was demonstrated in all samples (p = 0.00).
CONCLUSION: Oxidative DNA damage is an intervening variable for TP53 mutation in colorectal adenoma-carcinoma. Our data suggests that oxidative DNA damage is a potential marker of TP53 mutation in colorectal carcinogenesis.

Entities:  

Keywords:  Adenocarcinoma; Adenoma; DNA damage; Immunohistochemistry; Tumor suppressor protein p53

Mesh:

Substances:

Year:  2016        PMID: 27342962     DOI: 10.1007/s12029-016-9846-0

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  28 in total

1.  [p53 in clinical contexts: yes or not?].

Authors:  Ulysses Ribeiro; Adriana Vaz Safatle-Ribeiro
Journal:  Arq Gastroenterol       Date:  2006-05-08

2.  Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.

Authors:  K Yamaguchi; K Sugano; N Fukayama; Y Nakashima; K Saotome; T Yokoyama; T Yokota; H Ohkura
Journal:  Am J Gastroenterol       Date:  1997-02       Impact factor: 10.864

3.  Biomarkers of oxidative stress: methods and measures of oxidative DNA damage (COMET assay) and telomere shortening.

Authors:  Muthuswamy Balasubramanyam; Antonysunil Adaikalakoteswari; Zaheer Sameermahmood; Viswanathan Mohan
Journal:  Methods Mol Biol       Date:  2010

4.  Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community.

Authors:  M R Oliva; F Ripoll; P Muñiz; A Iradi; R Trullenque; V Valls; E Drehmer; G T Sáez
Journal:  Mol Carcinog       Date:  1997-04       Impact factor: 4.784

Review 5.  Oxidants, antioxidants, and the degenerative diseases of aging.

Authors:  B N Ames; M K Shigenaga; T M Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

Authors:  H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

7.  An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.

Authors:  B Vojtĕsek; J Bártek; C A Midgley; D P Lane
Journal:  J Immunol Methods       Date:  1992-07-06       Impact factor: 2.303

8.  Analysis of oxidative DNA damage in patients with colorectal cancer.

Authors:  Marcelo L Ribeiro; Denise G Priolli; Daniel D C Miranda; Demétrius P Arçari; José Pedrazzoli; Carlos A R Martinez
Journal:  Clin Colorectal Cancer       Date:  2008-07       Impact factor: 4.481

9.  ß-Catenin, Cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy.

Authors:  Linda Brand; Johanna Munding; Christian P Pox; Wibke Ziebarth; Markus Reiser; Dietrich Hüppe; Wolff Schmiegel; Anke Reinacher-Schick; Andrea Tannapfel
Journal:  Int J Colorectal Dis       Date:  2013-03-21       Impact factor: 2.571

10.  Functional clustering of time series gene expression data by Granger causality.

Authors:  André Fujita; Patricia Severino; Kaname Kojima; João Ricardo Sato; Alexandre Galvão Patriota; Satoru Miyano
Journal:  BMC Syst Biol       Date:  2012-10-30
View more
  2 in total

Review 1.  The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders.

Authors:  Camila Dos Santos Leite; Gabriel Alves Bonafé; Juliana Carvalho Santos; Carlos Augusto Real Martinez; Manoela Marques Ortega; Marcelo Lima Ribeiro
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

Review 2.  Current and future biomarkers in colorectal cancer.

Authors:  George Zarkavelis; Stergios Boussios; Alexandra Papadaki; Konstantinos H Katsanos; Dimitrios K Christodoulou; George Pentheroudakis
Journal:  Ann Gastroenterol       Date:  2017-09-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.